Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 1/2010

01.02.2010

Interventional Therapies for Controlling Pelvic Pain: What is the Evidence?

verfasst von: Isabel C. Green, Sarah L. Cohen, Dayna Finkenzeller, Paul J. Christo

Erschienen in: Current Pain and Headache Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Chronic pelvic pain (CPP) has many potential causes and is often a complex disorder with multiple contributing etiologies. The evaluation and treatment of women with CPP often requires a multidimensional approach. The treatment of CPP consists of two approaches: 1) treatment of pain itself or global treatment, and 2) treatment of disease-specific etiologies. Most often, treatment requires a combination of both approaches. This article reviews recent literature in the global treatment of CPP, including pharmacologic, psychotherapy, and neuroablative, as well as specific interventions for endometriosis, interstitial cystitis, pelvic adhesive disease, adenomyosis, and pelvic venous congestion.
Literatur
1.
Lippman SA, Warner M, Samuels S, et al.: Uterine fibroids and gynecologic pain syndrome in a population-based study. Fertil Steril 2003, 80:1488.CrossRefPubMed
2.
Zondervan KT, Yudkin PL, Vessey MP, et al.: Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynaecol 1999, 106:1149.PubMed
3.
Grace VM, Zondervan KT: Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnoses and use of health services. Aust N Z J Public Health 2004, 28:369.CrossRefPubMed
4.
Mathias SD, Kupperman M, Liberman RF, et al.: Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996, 87:321.CrossRefPubMed
5.
Farquhar CM, Steiner CA: Hysterectomy rates in the United States 1990–1997. Obstet Gynecol 2002, 99:229.CrossRefPubMed
6.
Zondervan KT, Yudkin PL, Vessey MP, et al.: Chronic pelvic pain in the community: symptoms, investigations, and diagnoses. Am J Obstet Gynecol 2001, 184:1149.CrossRefPubMed
7.
8.
•• Kroenke K, Krebs EE, Bair MJ: Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry 2009, 31:206–219. This article offers an evidenced-based approach and review of pharmacologic interventions for the treatment of chronic pain. It explores the use of NSAIDs, narcotics, and other alternatives medications, and touches on challenges of chronic narcotic use.CrossRefPubMed
9.
Adams EH, Breiner S, Cicero TJ, et al.: A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 2006, 31:455–476.CrossRef
10.
Chou R, Clark E, Helfand M: Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003, 26:1026–1048.CrossRefPubMed
11.
O’Mally PG, Jackson JL, Santoro J, et al.: Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999, 48:980–990.
12.
Lunn MP, Hughes RA, Wiffen PJ: Duloxetine for treating peripheral neuropathy of chronic pain. Cochrane Database Syst Rev 2009, 7:CD007115.
13.
Brown CS, Franks AS, Wan J, Ling FW: Citalopram in the treatment of women with chronic pelvic pain: an open-label trial. J Reprod Med 2008, 53:191–195.PubMed
14.
Bajwa ZH, Simopoulos TT, Pal J, et al.: Low and therapeutic doses of antidepressants are associated with similar response in the context of multimodal treatment of pain. Pain Physician 2009, 12:893–900.PubMed
15.
Wiffen PJ, McQuay HJ, Edwards JE, Moore RA: Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005, 20:CD005452.
16.
Sator-Katzenschlager SM, Scharbert G, Kress HG, et al.: Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr 2005, 117:761–768.CrossRefPubMed
17.
Roman H, Puscasiu L: Guidelines for the management of painful endometriosis. Chirurgia 2008, 103:265–274.PubMed
18.
Kroner-Herwig B: Chronic pain syndromes and their treatment by psychological interventions. Curr Opin Psychiatry 2009, 22:200–204.CrossRefPubMed
19.
•• Eccleston C, Palermo TM, Williams AC, et al.: Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev 2009, 15:CD003968. This literature review explores evidence supporting the role of psychological therapies as intervention for chronic pain.
20.
Haugstad GK, Haugstad TS, Kirste UM, et al.: Continuing improvement of chronic pelvic pain in women after short-term Mensendieck somatocognitive therapy: results of a 1-year follow up study. Am J Obstet Gynecol 2008, 199:615.e1–e8.
21.
Turk DC, Swanson KS, Tunks ER: Psychological approaches in the treatment of chronic pain patients: when pills, scalpels, and needles are not enough. Can J Psychiatry 2008, 53:213–223.PubMed
22.
Molton IR, Graham C, Stoelb BL, Jensen MP: Current psychological approaches to the management of chronic pain. Curr Opin Anaesthesiol 2007, 20:485–489.CrossRefPubMed
23.
Butler AC, Chapman JE, Forman EM, Beck AT: The empirical status of cognitive behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006, 26:17–31.CrossRefPubMed
24.
Candido K, Stevens RA: Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol 2003, 17:407–428.CrossRefPubMed
25.
Soysal ME, Soysal S, Gurses E, Ozer S: Laparoscopic presacral neurolysis for endometriosis-related pelvic pain. Hum Reprod 2003, 18:588–592.CrossRefPubMed
26.
Chen FP, Lo TS, Soong YK: Management of chylous ascites following laparoscopic presacral neurectomy. Hum Reprod 1998, 13:880–883.CrossRefPubMed
27.
Kwok A, Lam A, Ford R: Laparoscopic presacral neurectomy: a review. Obstet Gynecol Surv 2001, 56:99–104.CrossRefPubMed
28.
Plancarte R, Amescua C, Patt RB, Aldrete JA: Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 1990, 73:236–239.PubMed
29.
Wechsler RJ, Maurer PM, Halpern EJ, Frank ED: Superior hypogastric plexus block for chronic pelvic pain in the presence of endometriosis: CT techniques and results. Radiology 1995, 196:103–106.PubMed
30.
Michalek P, Dutka J: Computed tomography-guided anterior approach to the superior hypogastric plexus for noncancer pelvic pain: a report of two cases. Clin J Pain 2005, 21:553–556.CrossRefPubMed
31.
Cariati M, De Martini G, Pretolesi F, Roy MT: CT-guided superior hypogastric plexus block. J Comput Assist Tomogr 2002, 26:428–431.CrossRefPubMed
32.
Plancarte R, de Leon-Casasola OA, El-Helaly M, et al.: Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth 1997, 22:562–568.PubMed
33.
de Oliveira R, dos Reis MP, Prado WA: The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004, 110:400–408.CrossRefPubMed
34.
Plancarte R, Amescua C, Patt RB: Presacral blockade of the ganglion of Walther (ganglion impar). Anesthesiology 1990, 73:A751.
35.
Reig E, Abejón D, del Pozo C, et al.: Thermocoagulation of the ganglion impar or ganglion of Walther: description of a modified approach. Preliminary results in chronic, nononcological pain. Pain Pract 2005, 5:103–110.CrossRefPubMed
36.
Swofford JB, Ratzman DM: A transarticular approach to blockade of the ganglion impar (ganglion of Walther). Reg Anesth Pain Med 1998, 23:103.CrossRef
37.
•• Practice Committee of American Society for Reproductive Medicine: Treatment of pelvic pain associated with endometriosis. Fertil Steril 2008, 90(Suppl 5):S260–S269. This article outlines current recommendations for treatment strategy for endometriosis.
38.
39.
Ferrero S, Camerini G, Ragni N, et al.: Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study. Hum Repro 2009 Oct 10 (Epub ahead of print).
40.
•• Vercellini P: Endometriosis: current therapies and new pharmacological developments. Drugs 2009, 69:649–675. This article includes detailed descriptions of medical management options, including mechanisms of action.CrossRefPubMed
41.
Fedele L, Somigliana E, Frontino G, et al.: New drugs in development for the treatment of endometriosis. Expert Opin Investig Drug 2008, 17:1187–1202.CrossRef
42.
Yap C, Furness S, Farquhar C: Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev 2004, 3:CD003678.PubMed
43.
Flower A, Liu JP, Chen S: Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev 2009, 3:CD006568.PubMed
44.
Wayne PM, Kerr CE, Schnyer RN, et al.: Japanese-style acupuncture for endometriosis-related pelvic pain in adolescents and young women: results of a randomized sham-controlled trial. J Pediatr Adolesc Gynecol 2008, 21:247–257.CrossRefPubMed
45.
Jacobson TZ, Duffy JM, Barlow D: Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2009, 4:CD001300.PubMed
46.
Catenacci M, Sastry S, Falcone T: Laparoscopic surgery for endometriosis. Clin Obstet Gynecol 2009, 52:351–361.CrossRefPubMed
47.
Hart R, Hickey M, Maouris P, Buckett W: Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev 2008, 2:CD004992.PubMed
48.
Shakiba K, Bena JF, McGill KM, et al.: Surgical treatment of endometriosis: a 7-year follow up on the requirement for further surgery. Obstet Gynecol 2008, 111:1285–1292.PubMed
49.
Mattoras R, Elorriaga MA, Pijoan JI, et al.: Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone therapy. Fertil Steril 2002, 77:303–308.CrossRef
50.
•• Stepniewska A, Pomini P, Guerriero M, et al.: Colorectal endometriosis: benefits of long-term follow-up in patients who underwent laparoscopic surgery. Fertil Steril 2009 Oct 15 (Epub ahead of print). This is a well-organized overview of theories of pain, medical, and surgical interventions.
51.
52.
Hanno P, Nordling J, van Ophoven A: What is new in bladder pain syndrome/interstitial cystitis? Curr Opin Urol 2008, 18:353–358.CrossRefPubMed
53.
Hanno PM: Interstitial cystitis epidemiology, diagnostic criteria, clinical markers. Rev Urol 2002, 4(Suppl 1):S3–S8.PubMed
54.
van de Merwe JP, Nordling J, Bouchelouche P, et al.: Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008, 53:60–67.CrossRefPubMed
55.
•• Moutzouris DA, Falagas ME: Interstitial cystitis: an unsolved enigma. Clin J Am Soc Neph 2009, 4:1844–1857. This article provides a concise yet comprehensive review of recent literature surrounding diagnosis and management of IC. Included is a discussion surrounding the evolving definition of IC along with recent statistics on prevalence. Theories on pathophysiology, clinical presentation, diagnostic strategies, and treatment options are also addressed. CrossRef
56.
•• Shorter B, Lesser M, Moldwin RM, Kushner L: Effect of comestibles on symptoms of interstitial cystitis. J Urol 2007, 178:145–152. The results from a validated questionnaire used to assess the impact of various foods, beverages, and medications on symptoms related to IC are presented in this article. Several items are implicated in the exacerbation of IC.CrossRefPubMed
57.
•• Dimitrakov J, Kroenke K, Steers WD, et al.: Pharmacologic management of painful bladder syndrome/interstitial cystitis. Arch Intern Med 2007, 167:1922–1929. This is a review of 21 randomized controlled trials evaluating the efficacy of various oral and intravesicular medications in the treatment of IC. The authors concluded that only PPS demonstrated sufficient beneficial effect in the management of IC, and that data on other agents are insufficient for further recommendation.CrossRefPubMed
58.
van Ophoven A, Heinecke A, Hertle L: Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis. Urology 2005, 66:707–711.CrossRefPubMed
59.
Sant GR, Propert KJ, Hanno PM, et al.: A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 2003, 170:810–815.CrossRefPubMed
60.
van Ophoven A, Hertle L: Long-term results of amitriptyline treatment for interstitial cystitis. J Urol 2005, 174:1837–1840.CrossRefPubMed
61.
Marinkovic SP, Moldwin R, Gillen LM, Stanton SL: The management of painful bladder syndrome in women. BMJ 2009, 239:337–342.
62.
Sairanen J, Forsell T, Ruutu M: Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 2004, 171:2138–2141.CrossRefPubMed
63.
Soucy F, Gregoire M: Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J Urol 2005, 173:841–843.CrossRefPubMed
64.
•• Dawson TE, Jamison J: Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev 2007, 4:CD006113. This Cochrane review complied analysis of recent publications evaluating the efficacy of intravesical therapies for treatment of IC. Although data on the majority of treatments yielded mixed results, both BCG and oxybutynin were highlighted as potentially promising agents for the future.PubMed
65.
Cervigni M, Natale F, Natasa L, et al.: A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J 2008, 19:943–947.CrossRef
66.
Daha L, Lazar D, Simak R, Heinz P: The effects of intravesical pentosan polysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: preliminary results. Int Urogynecol J 2008, 19:987–990.CrossRef
67.
Chuang YC, Lee WC, Lee WC, Chiang PH: Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol 2009, 182:1393–1400.CrossRefPubMed
68.
Toft BR, Nordling J: Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Curr Opin Urol 2006, 16:268–272.CrossRefPubMed
69.
Giannantoni A, Porena M, Costantini E, et al.: Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow-up. J Urol 2008, 179:1031–1034.CrossRefPubMed
70.
Otten DP, Teichman JM: What is the value of cystoscopy with hydrodistention for interstitial cystitis? Urology 2005, 66:494–499.CrossRef
71.
Hsieh CH, Hsieh CJ, Chang HC: Treatment of interstitial cystitis with hydrodistention and bladder training. Int Urogynecol J 2008, 19:1379–1384.CrossRef
72.
Oeslemans D, van Kerrebroeck P: Sacral nerve stimulation for neuromodulation of the lower urinary tract. Neurol Urodyn 2008, 27:28–33.CrossRef
73.
Whitemore KE, Payne CK, Diokno AC, Lukban JC: Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J 2003, 14:305–309.CrossRef
74.
Siegel S, Paszkiewicz E, Kirkpatrick C, et al.: Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 2001, 166:1742–1745.CrossRefPubMed
75.
Everaert K, Devulder J, De Muynk M, et al.: The pain cycle: implication for the diagnosis and treatment of pelvic pain syndromes. Int Urogynecol J Pelvic Floor Dysfunct 2001, 12:9–14.CrossRefPubMed
76.
Kapural L, Narouze SN, Janicki TI, Mekhail N: Spinal cord stimulation is an effective treatment for the chronic intractable visceral pelvic pain. Pain Med 2006, 7:440–443.CrossRefPubMed
77.
Comiter CV: Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003, 169:1369–1373.CrossRefPubMed
78.
Peters KM, Killinger KA, Boguslawski BM, Boura JA: Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurol Urodyn 2009 Sept 28 (Epub ahead of print).
79.
Rössberger J, Fall M, Jonsson O, Peeker R: Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology 2007, 70:638–642.CrossRefPubMed
80.
Stones RW, Mountfield J: Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev 2005, 2:CD000387.
81.
Keltz M, Gera PS, Olive DL: Prospective randomized trial of right-sided paracolic adhesiolysis for chronic pelvic pain. JSLS 2006, 10:443–446.PubMed
82.
•• Roman H, Hulsey TF, Marpeau L, Hulsey TC: Why laparoscopic adhesiolysis should not be the victim of a single randomized clinical trial. Am J Obstet Gynecol 2009, 200:136.e1–e4. This thought-provoking editorial investigates the current literature and challenges regarding evidence for or against adhesiolysis.CrossRef
83.
Rabinovici J, Stewart EA: New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:617–635.CrossRefPubMed
84.
Farquhar C, Brosens I: Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:603–616.CrossRefPubMed
85.
Levgur M: Diagnosis of adenomyosis: a review. J Reprod Med 2007, 52:177–193.PubMed
86.
Yoon SW, Kim KA, Cha SH, et al.: Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis. Fertil Steril 2008, 90:2018.e13–e15.CrossRef
87.
Fukunishi H, Funaki K, Sawada K, et al.: Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol 2008, 15:571–579.CrossRefPubMed
88.
Chen CL, Li FJ, Liu P, et al.: The relevance between the effect on dysmenorrheal and the time of surgery of artery embolization in the treatment of adenomyosis [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 2008, 43:884–887.PubMed
89.
Chen Cl, Liu P, Zeng BL, et al.: Intermediate and long term clinical effects of uterine arterial embolization in treatment of adenomyosis [in Chinese]. Zhongua Fu Chan Ke Za Zhi 2006, 41:660–663.
90.
Ganeshan A, Upponi S, Hon LQ, et al.: Chronic pelvic pain due to pelvic congestion syndrome: the role of diagnostic and interventional radiology. Cardiovasc Intervent Radiol 2007, 30:1105–1111.CrossRefPubMed
91.
Nicholson T, Basile A: Pelvic congestion syndrome: who should we treat and how? Tech Vasc Interv Radiol 2006, 9:19–23.CrossRefPubMed
92.
Liddle AD, Davies AH: Pelvic congestion syndrome: chronic pelvic pain caused by ovarian and internal iliac varices. Phlebology 2007, 22:100–104.CrossRefPubMed
93.
Soysal ME, Soysal S, Vicdan K, Ozer S: A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion. Hum Reprod 2001, 16:931–939.CrossRefPubMed
94.
Farquhar CM, Rogers V, Franks S, et al.: A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion. Br J Obstet Gynaecol 1989, 96:1153–1162.PubMed
95.
Shokeir T, Amr M, Abdelshaheed M: The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled study. Arch Gynecol Obstet 2009, 280:437–443.CrossRefPubMed
96.
Creton HD, Hennequin L, Kohler F, Allaert FA: Embolisation of symptomatic pelvic veins in women presenting with non-saphenous varicose veins of pelvic origin: three year follow-up. Eur J Vasc Endovasc Surg 2007, 34:112–117.CrossRefPubMed
97.
Kim HS, Malhotra AD, Rowe PC, et al.: Embolotherapy for pelvic congestion syndrome: long term results. J Vasc Interv Radiol 2006, 17:289–297.PubMedCrossRef
Metadaten
Titel
Interventional Therapies for Controlling Pelvic Pain: What is the Evidence?
verfasst von
Isabel C. Green
Sarah L. Cohen
Dayna Finkenzeller
Paul J. Christo
Publikationsdatum
01.02.2010
Verlag
Current Science Inc.
Erschienen in
Current Pain and Headache Reports / Ausgabe 1/2010
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-009-0089-7

Weitere Artikel der Ausgabe 1/2010

Current Pain and Headache Reports 1/2010 Zur Ausgabe

OriginalPaper

Current Developments in Intraspinal Agents for Cancer and Noncancer Pain

OriginalPaper

The “Other” Headaches: Primary Cough, Exertion, Sex, and Primary Stabbing Headaches

OriginalPaper

Chronic Orofacial Pain

OriginalPaper

Chronic Headaches and the Neurobiology of Somatization

OriginalPaper

Chronic Headache: The Role of the Psychologist

OriginalPaper

Treating Pain on the Battlefield: A Warrior’s Perspective

Neu im Fachgebiet AINS

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise